FDA Public Meeting: Patient-Focused Drug Development for Vitiligo PriyankaMarch 22, 2021November 27, 2022Uncategorized Post navigation PreviousNext Patient panelist Priyanka discussed her experience with vitiligo, the range of treatments, and the treatment burden with the FDA to advance better treatments and a cure for patients with vitiligo. Timestamp: 2:26:07 – 2:28:16 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Like Loading... Related